Search

Thank You For Requesting The STELARA® Information Kit

You can now access your Information Kit electronically, and learn about what's possible with STELARA®.

You will also receive an e-mail within the next 24 hours that contains a link to your E-kit. Click on the link to build and read your E-kit at your convenience.

To ensure you receive timely information about STELARA® and plaque psoriasis, please add admin@info.janssenbiotech.com to your e-mail address book. In the meantime, explore our website to learn more about STELARA® and start taking advantage of all the resources available to you.

The exact cause of psoriasis is unknown. However we do know that the immune system, environmental factors, and family history can play a role. The immune system speeds up, which causes inflammation and a large number of skin cells to grow. Instead of falling off (shedding), the cells pile up on the surface of the skin, forming psoriatic plaques.

Learn more about the role of the immune system in plaque psoriasis and see how STELARA® works differently to treat moderate or severe plaque psoriasis.

Certain things may cause psoriasis to flare. These include stress, skin injuries, strep infections, and certain medications, including anti-malarial drugs, beta-blockers, lithium, and oral corticosteroids. Weather can also trigger psoriatic symptoms, especially when it is cold and dry outside. During the winter, moisture leaves the skin because of both the cold and dry air, which may make psoriasis worse.

There is currently no known cure for psoriasis. However, there are certain medications, including biologics, that can help treat psoriasis. People with psoriasis should speak to their doctors about finding the right treatment(s) to help manage their symptoms. Treatments may include medications that are applied to the skin, ultraviolet light therapy, medications taken by mouth, or those given by injection.

Your doctor will prescribe a psoriasis treatment for you based on many things, including how severe and where your psoriasis is on your body, your age, and your medical history. Some common treatments include:

Topical treatments

Topical treatments, such as creams and gels, are often given for mild to moderate psoriasis. They are rubbed directly on the surface of the skin. Topicals help slow down skin cell growth and help lessen redness and inflammation. Examples include Dovonex®* (calcipotriene), a synthetic vitamin D cream, Tazorac®* (tazarotene), a vitamin A derivative, and steroid creams. Other treatments commonly used are coal tar and anthralin.

Light therapies

In light therapy, the skin—or just the psoriatic plaque—is exposed to ultraviolet light (UVB or Psoralen plus UVA [PUVA]). The treatment helps slow down skin cell growth and kill T cells (a type of immune cell). Light therapies are used for moderate to severe psoriasis. One type of light therapy, PUVA, uses medication (psoralen) with ultraviolet light (UVA). PUVA is used for people with severe psoriasis. Treatment is usually given in a dermatologist's office or psoriasis clinic.

Systemic therapies

Systemic medications work throughout the body. They can be taken in pill form or given by injection. Examples of systemic medications are retinoids, such as Soriatane®* (acitretin), and medications that suppress the immune system, such as Neoral®* (cyclosporine) and methotrexate.

Biologic treatments

Biologics are the latest advancement in systemic psoriasis treatment. They are injectable treatments for people with moderate or severe plaque psoriasis. Biologic treatments can target the immune system in different ways. STELARA® works by targeting your body’s immune system and blocking 2 proteins (IL-12 and IL-23) that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is a prescription medicine approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

STELARA® is a biologic that targets IL-12 and IL-23 to help provide relief from the symptoms associated with plaque psoriasis, such as plaque thickness, scaling, and redness—with 4 doses a year after 2 starter doses.

STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider. Each injection is given using a small needle. STELARA® is available in 45 mg or 90 mg doses; your doctor will choose the right dose for you. Make sure you keep all your scheduled follow-up appointments.Learn more about STELARA®.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome. Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

*Indicated trademarks are registered trademarks of their respective owners.

Right now, as many as 7.5 million people in the U.S. are living with psoriasis, and about 80% have plaque psoriasis. Between 150,000 and 260,000 new cases are diagnosed every year, and most people are diagnosed before age 40. Psoriasis affects both men and women and is more common among Caucasians of northern European descent than among African-Americans or Asians. Genetics may also play a role, with one-third of people having a family history of the disease.

There are many great resources available to help you learn more about psoriasis. You can find out about symptoms, treatments, research studies, and educational programs.

The National Psoriasis Foundation has a large amount of information at www.psoriasis.org. Visit their online forum where you can connect with others living with psoriasis, or talk to a mentor if you’ve recently been told you have psoriasis and are looking for support. You can also call the National Psoriasis Foundation at 1-800-723-9166.

Psoriasis Cure Now! is also a great resource to learn more about psoriasis and connect with others. Go to www.psoriasis-cure-now.org, call 1-301-571-2393, or visit their online forum and join their community network.

For a more extensive list of psoriasis-related resources, go to Psoriasis Links.

STELARA® is a prescription medicine that is approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

Only your doctor can determine whether STELARA® is right for you. It is a prescription psoriasis medicine approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome. Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

Do not take STELARA® if you are allergic to ustekinumab or any of the ingredients in STELARA (L-histidine and L-histidine monohydrochloride monohydrate, polysorbate and sucrose).

The convenient dosing of STELARA® offers a full 12 weeks between treatments after two starter doses. STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training. Each injection is given using a small needle. STELARA® is available in 45 mg or 90 mg doses; your doctor will choose the right dose of STELARA® for you. You will start off by taking the first starter dose of STELARA®, followed by a second starter dose four weeks later. You will then receive a maintenance dose every 12 weeks thereafter.

STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training. Each injection is given using a small needle. STELARA® is available in 45 mg or 90 mg doses; your doctor will choose the right dose for you. Make sure you keep all your scheduled follow-up appointments. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider.

Your healthcare provider will give you the injection on an area of your body that does not have plaques, and may give you your injection in a different area each time. If you are self-injecting with STELARA® you can inject in several places. It is recommended that you inject in your thighs or stomach area.

Your doctor will determine the dose that is right for you. For people weighing 220 pounds or less, the recommended dose is one 45 mg starter dose, followed by a second starter dose four weeks later. You will then receive a 45 mg maintenance dose every 12 weeks after that. For people weighing more than 220 pounds, the recommended dose is one 90 mg starter dose, followed by a second starter dose four weeks later. You will then receive a 90 mg maintenance dose every 12 weeks after that.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome.

Do not take STELARA® if you are allergic to ustekinumab or any of the ingredients in STELARA® (L-histidine and L-histidine monohydrochloride monohydrate, polysorbate and sucrose).

You and your doctor should discuss the risks and benefits of treatment with STELARA®. It is not known if STELARA® is safe and effective in children.

If you are interested in starting STELARA®, talk to your doctor. The following simple steps can help you and your doctor decide if STELARA® is right for you:

Make a list of questions – If you have any questions about your condition or treatment, make sure you get all the answers you need.

Keep a detailed record of your symptoms – Describe all the areas on your body that have plaque psoriasis and your symptoms since your last visit, including plaque thickness, scaling, and redness. Download our Psoriasis Symptom Monitor to help you keep track of your symptoms to share with your doctor.

Share your medical history – Make a list of all the names and dosages of any past and current medications. Talk with your doctor about how well the medications worked and if you were happy with the results.

No. STELARA® is not a steroid. STELARA® targets an underlying cause of plaque psoriasis—an overactive immune system. It blocks the action of IL-12 and IL-23, two proteins that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome.
Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

You should not receive a live vaccine while taking STELARA®. Before receiving STELARA®, tell your doctor if you have recently received or are scheduled to receive an immunization (vaccine). Tell your doctor if anyone in your house needs a vaccine. The viruses used in some types of vaccines can spread to people with a weakened immune system, and can cause serious problems. You should not receive the BCG vaccine during the one year before taking STELARA® or one year after you stop taking STELARA®. Non-live vaccinations received while taking STELARA® may not fully protect you from disease.

STELARA® helps reduce plaque thickness, scaling, and redness. 7 out of 10 people taking STELARA® saw at least 75% clearer skin at 12 weeks and 6 out of 10 people had their plaque psoriasis rated as cleared or minimal at 12 weeks. Nearly 8 out of 10 people who initially saw at least 75% clearer skin with STELARA® maintained their results with continued therapy at 2 years*

Individual results may vary.

*Includes only people who responded at 7 and 10 months. They were allowed to use topical medicines along with STELARA® after nearly one and a half years.

Everyone responds to treatment differently. However, in a medical study, 7 out of 10 people taking STELARA® saw at least 75% clearer skin at 12 weeks and 6 out of 10 people had their plaque psoriasis rated as cleared or minimal at 12 weeks. Nearly 8 out of 10 people who initially saw at least 75% clearer skin with STELARA® maintained their results with continued therapy at 2 years*.

Individual results may vary.

*Includes only people who responded at 7 and 10 months. They were allowed to use topical medicines along with STELARA® after nearly one and a half years.

STELARA® targets an underlying cause of plaque psoriasis—an overactive immune system. It blocks two proteins called IL-12 and IL-23 that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is a biologic medication. Biologics are injectable treatments that deliver the medication into the body to target an underlying cause of plaque psoriasis—an overactive immune system. STELARA® specifically targets two proteins, IL-12 and IL-23, that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome. Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

The first step in self-injecting is for you and your doctor to decide if self-injection is right for you. If your doctor decides that you or a caregiver may be able to give your injections of STELARA® at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject STELARA® yourself until you have been shown the right way to give the injections by your doctor or nurse.

Other supplies that you need include an antiseptic wipe, cotton balls or gauze pads and a puncture-resistant container (sharps disposal container). You can pick up the antiseptic wipes, cotton balls, and a puncture-resistant container (sharps disposal container) at your local drug store.

Use STELARA® exactly as prescribed by your doctor. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider. You will have to go to your doctor’s office for your first injection so your healthcare professional can show you how to use a prefilled syringe. After that, you can start injecting yourself.

Check the package to make sure that it is the right dose and check the expiration date on the prefilled syringe and carton to make sure it has not passed. You want to make sure the prefilled syringe is not damaged and that the liquid inside is colorless to light yellow. Do not use if it is frozen, discolored, cloudy, or has large particles. Do not shake the prefilled syringe at any time. Hold your prefilled syringe with the covered needle pointing upward to check.

Do not use the prefilled syringe if the liquid looks frozen, discolored, cloudy, or contains large particles. If you have any questions about what is normal and what is not, call 1-800-JANSSEN (1-800-526-7736).

If your doctor decides that a caregiver or a friend may give your injections at home, he or she should receive training on the right way to prepare and inject STELARA®. He or she should not inject you until trained by a healthcare provider.

Put the used syringe in a puncture-resistant container (sharps disposal container) right away after use. Do not throw away loose syringes in your household trash. Follow your community’s guidance for the right way to dispose of your sharps container. Always keep the sharps disposal container out of the reach of children.

When you receive your STELARA® dose, make sure to immediately store your prefilled syringe in the refrigerator until you are ready to use it. Do not freeze or shake the prefilled syringe and keep it in the carton to protect it from light.

Once you have the needle uncapped, make sure that you do not let the needle touch any surface and make sure that you don’t use the prefilled syringe if it is dropped without the needle cover in place. Do not handle the needle cover if you are allergic to latex.

After you’ve cleaned the injection spot with an alcohol wipe, use the hand that is not holding the prefilled syringe to pinch the skin just outside of the cleaned area and hold firmly. Using a quick motion, insert the needle into your pinched skin using a 45-degree angle. Inject all the medicine by using your thumb to push the plunger head down, until the plunger head is between the needle wings.

If you see a small amount of blood or liquid where you injected, that is normal. Just press a cotton ball or gauze pad to it if needed. Do not rub. If you want, you can cover the area with an adhesive bandage.

There are many ways to safely dispose of your used syringe if you do not have a puncture-resistant container (sharps disposal container), including:

- Using a drop box at your doctor’s office, clinics, local pharmacies, or health departments

- Finding a household hazardous waste collection site

- Participating in a syringe and used needle exchange program

- Signing up for the STELARA® Safe Returns® program

You will need a puncture-resistant container (sharps disposal container). Ask your doctor for instructions on the right way to dispose of the container. You need to follow your community guidelines for the right way to dispose of used syringes. Do not throw away used syringes or a sharps disposal container in your household trash.

When you sign up with STELARA® Safe Returns®, you’ll receive a Safe Returns® package in the mail. Follow the instructions inside the package to return your used syringe in the postage-paid mail-back box when your disposal container is full. To sign up, call StelaraSupport™ at 1-877-STELARA (1-877-783-5272).

STELARA® is taken 4 times a year after 2 starter doses. After your first starter dose, wait 4 weeks until your 2nd starter dose, then 12 weeks after that. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider.

STELARA® must be stored in the refrigerator (but NOT in the freezer compartment). STELARA® should not be frozen or shaken. Keep the product in the original carton to protect it from light until the time of use. Refrigerate it immediately at 36°F to 46°F (2°C – 8°C).

If you need to store your STELARA® medication before your doctor appointment or if you are self-injecting, always store STELARA® under proper conditions. Never keep STELARA® beyond the expiration date printed on the carton and the label.

StelaraSupport™ has several different services at no cost to help you get started and stay on track with your treatment. StelaraSupport™ services include:

Cost Support: We understand that everyone's financial situation is different. Our Case Coordinators can help you identify resources that may assist you in reducing your out-of-pocket medication costs and help you find a program that could keep STELARA® affordable if your insurance or financial situation changes. Find more information on plaque psoriasis treatment cost support options and see if you qualify.

Insurance Help: If either you or your doctor contacts StelaraSupport™, our Case Coordinators can help you learn about and verify your insurance benefits. They’ll also help explain your potential out-of-pocket medication costs for STELARA®.

Medication Reminders: To help you stay on track with your treatments, StelaraSupport™ can send you timely reminders —by phone, text, or e-mail—before your next dose is due.

Updates and Educational Materials: StelaraSupport™ provides important updates, as well as helpful tools to help manage your plaque psoriasis.

For more information about the services listed above, visit StelaraSupport™.

Understanding your insurance coverage can be tricky. Since coverage policies can vary from plan to plan, it’s important to check if your medical and pharmacy benefits cover STELARA®. Case Coordinators can help you learn about and verify your insurance benefits. They’ll also help explain your potential out-of-pocket medication costs for STELARA®. You can contact StelaraSupport™ at 1-877-STELARA (1-877-783-5272), Monday through Friday, 8 AM to 8 PM ET. Please have your insurance information available when you call.

If you have questions about your insurance coverage for STELARA®, you can get personalized help from our Case Coordinators. They will help you learn about and verify your insurance benefits for STELARA®. They’ll also help explain your out-of-pocket costs.

There are programs available to provide assistance for people who have difficulty affording the medication costs for STELARA®. You are encouraged to call StelaraSupport™ at 1-877-STELARA (1-877-783-5272), Monday through Friday, 8 AM to 8 PM ET for more information. Case Coordinators are available to help you identify possible sources of funding.

Yes. If you have commercial insurance, our Instant Savings Program can help lower your out-of-pocket costs including co-pay, deductible, and co-insurance medication costs. If you qualify, your out-of-pocket costs will be $10 for each dose up to the maximum annual program benefit of $10,000 or 12 months from the card activation date, whichever comes first.

You may be eligible for Instant Savings if you have been given STELARA® by your doctor, are being treated for the FDA-approved use for STELARA®, AND currently have commercial insurance that covers medication costs for STELARA®. A Case Coordinator can provide you with more details and see if you are able to participate.

You are encouraged to call StelaraSupport™ to get information about how to get help paying for STELARA®. You can contact us at 1-877-STELARA (1-877-783-5272), Monday through Friday, 8 AM to 8 PM ET. Please have your insurance information ready when you call.

STELARA® can be covered in 2 ways: through your medical and/or pharmacy benefits. Your doctor’s staff
will investigate your healthcare coverage to see if your benefits cover STELARA®. Remind the doctor’s
staff to investigate both benefits before leaving the office. If your doctor’s office says that you are not
covered, call StelaraSupport™ (877-783-5272) to see about other financial options.

This free electronic kit is viewed on your computer. It provides helpful information about STELARA®, including safety and effectiveness. It also has tools that can help you talk to your doctor about how your plaque psoriasis is changing over time, and finding the best treatment options for you. The kit is available by request to everyone. Request your free STELARA® Information Kit now.

STELARA® is a prescription medicine that is approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

Only your doctor can determine whether STELARA® is right for you. It is a prescription psoriasis medicine approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome. Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

Do not take STELARA® if you are allergic to ustekinumab or any of the ingredients in STELARA (L-histidine and L-histidine monohydrochloride monohydrate, polysorbate and sucrose).

The convenient dosing of STELARA® offers a full 12 weeks between treatments after two starter doses. STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training. Each injection is given using a small needle. STELARA® is available in 45 mg or 90 mg doses; your doctor will choose the right dose of STELARA® for you. You will start off by taking the first starter dose of STELARA®, followed by a second starter dose four weeks later. You will then receive a maintenance dose every 12 weeks thereafter.

STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training. Each injection is given using a small needle. STELARA® is available in 45 mg or 90 mg doses; your doctor will choose the right dose for you. Make sure you keep all your scheduled follow-up appointments. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider.

Your healthcare provider will give you the injection on an area of your body that does not have plaques, and may give you your injection in a different area each time. If you are self-injecting with STELARA® you can inject in several places. It is recommended that you inject in your thighs or stomach area.

Your doctor will determine the dose that is right for you. For people weighing 220 pounds or less, the recommended dose is one 45 mg starter dose, followed by a second starter dose four weeks later. You will then receive a 45 mg maintenance dose every 12 weeks after that. For people weighing more than 220 pounds, the recommended dose is one 90 mg starter dose, followed by a second starter dose four weeks later. You will then receive a 90 mg maintenance dose every 12 weeks after that.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome.

Do not take STELARA® if you are allergic to ustekinumab or any of the ingredients in STELARA® (L-histidine and L-histidine monohydrochloride monohydrate, polysorbate and sucrose).

You and your doctor should discuss the risks and benefits of treatment with STELARA®. It is not known if STELARA® is safe and effective in children.

If you are interested in starting STELARA®, talk to your doctor. The following simple steps can help you and your doctor decide if STELARA® is right for you:

Make a list of questions – If you have any questions about your condition or treatment, make sure you get all the answers you need.

Keep a detailed record of your symptoms – Describe all the areas on your body that have plaque psoriasis and your symptoms since your last visit, including plaque thickness, scaling, and redness. Download our Psoriasis Symptom Monitor to help you keep track of your symptoms to share with your doctor.

Share your medical history – Make a list of all the names and dosages of any past and current medications. Talk with your doctor about how well the medications worked and if you were happy with the results.

No. STELARA® is not a steroid. STELARA® targets an underlying cause of plaque psoriasis—an overactive immune system. It blocks the action of IL-12 and IL-23, two proteins that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome.
Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

You should not receive a live vaccine while taking STELARA®. Before receiving STELARA®, tell your doctor if you have recently received or are scheduled to receive an immunization (vaccine). Tell your doctor if anyone in your house needs a vaccine. The viruses used in some types of vaccines can spread to people with a weakened immune system, and can cause serious problems. You should not receive the BCG vaccine during the one year before taking STELARA® or one year after you stop taking STELARA®. Non-live vaccinations received while taking STELARA® may not fully protect you from disease.

STELARA® helps reduce plaque thickness, scaling, and redness. 7 out of 10 people taking STELARA® saw at least 75% clearer skin at 12 weeks and 6 out of 10 people had their plaque psoriasis rated as cleared or minimal at 12 weeks. Nearly 8 out of 10 people who initially saw at least 75% clearer skin with STELARA® maintained their results with continued therapy at 2 years*

Individual results may vary.

*Includes only people who responded at 7 and 10 months. They were allowed to use topical medicines along with STELARA® after nearly one and a half years.

Everyone responds to treatment differently. However, in a medical study, 7 out of 10 people taking STELARA® saw at least 75% clearer skin at 12 weeks and 6 out of 10 people had their plaque psoriasis rated as cleared or minimal at 12 weeks. Nearly 8 out of 10 people who initially saw at least 75% clearer skin with STELARA® maintained their results with continued therapy at 2 years*.

Individual results may vary.

*Includes only people who responded at 7 and 10 months. They were allowed to use topical medicines along with STELARA® after nearly one and a half years.

STELARA® targets an underlying cause of plaque psoriasis—an overactive immune system. It blocks two proteins called IL-12 and IL-23 that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is a biologic medication. Biologics are injectable treatments that deliver the medication into the body to target an underlying cause of plaque psoriasis—an overactive immune system. STELARA® specifically targets two proteins, IL-12 and IL-23, that may play a role in plaque psoriasis. This may slow down how fast skin cells are made and may reduce inflammation.

STELARA® is not for everyone; only your doctor can decide if it’s right for you. STELARA® is a prescription medicine that affects your immune system. It can increase your chances of having serious side effects including infections, cancer, serious allergic reactions and a rare condition called reversible posterior leukoencephalopathy syndrome. Please read the Important Safety Information below and the Medication Guide for STELARA® to learn more about these and other risks for STELARA®. Discuss any questions you have with your doctor.

The first step in self-injecting is for you and your doctor to decide if self-injection is right for you. If your doctor decides that you or a caregiver may be able to give your injections of STELARA® at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject STELARA® yourself until you have been shown the right way to give the injections by your doctor or nurse.

Other supplies that you need include an antiseptic wipe, cotton balls or gauze pads and a puncture-resistant container (sharps disposal container). You can pick up the antiseptic wipes, cotton balls, and a puncture-resistant container (sharps disposal container) at your local drug store.

Use STELARA® exactly as prescribed by your doctor. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider. You will have to go to your doctor’s office for your first injection so your healthcare professional can show you how to use a prefilled syringe. After that, you can start injecting yourself.

Check the package to make sure that it is the right dose and check the expiration date on the prefilled syringe and carton to make sure it has not passed. You want to make sure the prefilled syringe is not damaged and that the liquid inside is colorless to light yellow. Do not use if it is frozen, discolored, cloudy, or has large particles. Do not shake the prefilled syringe at any time. Hold your prefilled syringe with the covered needle pointing upward to check.

Do not use the prefilled syringe if the liquid looks frozen, discolored, cloudy, or contains large particles. If you have any questions about what is normal and what is not, call 1-800-JANSSEN (1-800-526-7736).

If your doctor decides that a caregiver or a friend may give your injections at home, he or she should receive training on the right way to prepare and inject STELARA®. He or she should not inject you until trained by a healthcare provider.

Put the used syringe in a puncture-resistant container (sharps disposal container) right away after use. Do not throw away loose syringes in your household trash. Follow your community’s guidance for the right way to dispose of your sharps container. Always keep the sharps disposal container out of the reach of children.

When you receive your STELARA® dose, make sure to immediately store your prefilled syringe in the refrigerator until you are ready to use it. Do not freeze or shake the prefilled syringe and keep it in the carton to protect it from light.

Once you have the needle uncapped, make sure that you do not let the needle touch any surface and make sure that you don’t use the prefilled syringe if it is dropped without the needle cover in place. Do not handle the needle cover if you are allergic to latex.

After you’ve cleaned the injection spot with an alcohol wipe, use the hand that is not holding the prefilled syringe to pinch the skin just outside of the cleaned area and hold firmly. Using a quick motion, insert the needle into your pinched skin using a 45-degree angle. Inject all the medicine by using your thumb to push the plunger head down, until the plunger head is between the needle wings.

If you see a small amount of blood or liquid where you injected, that is normal. Just press a cotton ball or gauze pad to it if needed. Do not rub. If you want, you can cover the area with an adhesive bandage.

There are many ways to safely dispose of your used syringe if you do not have a puncture-resistant container (sharps disposal container), including:

- Using a drop box at your doctor’s office, clinics, local pharmacies, or health departments

- Finding a household hazardous waste collection site

- Participating in a syringe and used needle exchange program

- Signing up for the STELARA® Safe Returns® program

You will need a puncture-resistant container (sharps disposal container). Ask your doctor for instructions on the right way to dispose of the container. You need to follow your community guidelines for the right way to dispose of used syringes. Do not throw away used syringes or a sharps disposal container in your household trash.

When you sign up with STELARA® Safe Returns®, you’ll receive a Safe Returns® package in the mail. Follow the instructions inside the package to return your used syringe in the postage-paid mail-back box when your disposal container is full. To sign up, call StelaraSupport™ at 1-877-STELARA (1-877-783-5272).

STELARA® is taken 4 times a year after 2 starter doses. After your first starter dose, wait 4 weeks until your 2nd starter dose, then 12 weeks after that. If your doctor decides that you or a caregiver may give your injections at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject yourself until you or your caregiver has been properly trained by a healthcare provider.

STELARA® must be stored in the refrigerator (but NOT in the freezer compartment). STELARA® should not be frozen or shaken. Keep the product in the original carton to protect it from light until the time of use. Refrigerate it immediately at 36°F to 46°F (2°C – 8°C).

If you need to store your STELARA® medication before your doctor appointment or if you are self-injecting, always store STELARA® under proper conditions. Never keep STELARA® beyond the expiration date printed on the carton and the label.

WHAT IS STELARA®?

STELARA® is a prescription medicine approved to treat adults 18 years and older with moderate or severe plaque psoriasis that involves large areas or many areas of their body, who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet light alone or with pills).

STELARA® is a prescription medicine approved to treat adults 18 years and older with active psoriatic arthritis, either alone or with methotrexate.

STELARA® is a 45 mg or 90 mg injection given under the skin as directed by your doctor at weeks 0, 4, and every 12 weeks thereafter. It is administered by a healthcare provider or self-injected only after proper training.

RPLS is a rare condition that affects the brain and can cause death. The cause of RPLS is not known. If RPLS is found early and treated, most people recover.
Tell your doctor right away if you have any new or worsening medical problems including: headache, seizures, confusion, and vision problems.

Serious Allergic Reactions

Serious allergic reactions can occur. Get medical help right away if you have any symptoms such as: feeling faint, swelling of your face, eyelids, tongue, or throat, trouble breathing, throat or chest tightness, or skin rash.

Before receiving STELARA®, tell your doctor if you:

have any of the conditions or symptoms listed above for serious infections, cancers, or RPLS

ever had an allergic reaction to STELARA® or any of its ingredients. Ask your doctor if you are not sure.

are allergic to latex. The needle cover on the prefilled syringe contains latex.

If your doctor decides that you or a caregiver may give your injections of STELARA® at home, you should receive training on the right way to prepare and inject STELARA®. Do not try to inject STELARA® yourself until you or your caregiver has been shown how to inject STELARA® by your doctor or nurse.

Stelara - HCP overlay

Are You A Healthcare Professional?

The information contained in this section of the site is intended for U.S. healthcare professionals only.

Click on the appropriate button below.

Your Email: *

Your Name: *

You are going to email the following:

Message Subject:
(Your Name) has forwarded a page to you from Stelara®

Message Body:
(Your Name) thought you would like to see this page from the Stelara® web site.

Send To A Friend

If you would like to send this information to a friend, simply fill in your name, the name and e-mail address of the recipient, and click the "Submit" button. Your friend will receive an e-mail with a link to this page on STELARAinfo.com, along with a notification that you requested it.

We do not maintain or capture these names in any way. Once you have sent this information, it is immediately deleted from our system (see our Privacy Policy for more information).

This site is published by Janssen Biotech Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

The information on this site is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.